Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HELENA A YU

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1871791665
CMS profile
1213651
Location
NEW YORK, NY

General Payments · PY2018–2024

$175,471.65

  • Reported across 134 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$54,520.30

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $24,349.68 7
Janssen Scientific Affairs, LLC $5,400.00 4
Novocure Inc. $5,098.57 2
Daiichi Sankyo Inc. $3,085.00 2
E.R. Squibb & Sons, L.L.C. $3,043.76 2
ABBVIE INC. $3,037.50 1
Janssen Global Services, LLC $2,700.00 1
Janssen Biotech, Inc. $2,450.00 2
TAIHO ONCOLOGY, INC. $2,100.00 1
AstraZeneca UK Limited $1,605.00 1
ARRAY BIOPHARMA INC $1,440.00 1
Orion Corporation $210.79 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $5,968.03 7
PY2019 $23,118.52 24
PY2020 $16,883.33 17
PY2021 $24,938.50 15
PY2022 $18,212.61 16
PY2023 $31,830.36 30
PY2024 $54,520.30 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $3,037.50 01/31/2024 Consulting Fee Undisputed 01/23/2026 1106383626 CMS
ARRAY BIOPHARMA INC $1,440.00 11/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132133221 CMS
AstraZeneca UK Limited $1,605.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1094050472 CMS
Daiichi Sankyo Inc. $1,212.50 03/21/2024 Consulting Fee Undisputed 01/23/2026 1089501164 CMS
Daiichi Sankyo Inc. $1,872.50 12/19/2024 Consulting Fee Undisputed 01/23/2026 1089501162 CMS
E.R. Squibb & Sons, L.L.C. $51.26 09/14/2024 Food and Beverage Undisputed 01/23/2026 1101500701 CMS
E.R. Squibb & Sons, L.L.C. $2,992.50 10/24/2024 Consulting Fee Undisputed 01/23/2026 1101500662 CMS
Janssen Biotech, Inc. $350.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1078455414 CMS
Janssen Biotech, Inc. $2,100.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1078439362 CMS
Janssen Global Services, LLC $2,700.00 05/14/2024 Consulting Fee Undisputed 01/23/2026 1077592085 CMS
Janssen Scientific Affairs, LLC $1,012.50 05/15/2024 Consulting Fee Undisputed 01/23/2026 1078856148 CMS
Janssen Scientific Affairs, LLC $1,350.00 08/27/2024 Consulting Fee Undisputed 01/23/2026 1078855758 CMS
Janssen Scientific Affairs, LLC $2,700.00 09/23/2024 Consulting Fee Undisputed 01/23/2026 1078856136 CMS
Janssen Scientific Affairs, LLC $337.50 09/24/2024 Consulting Fee Undisputed 01/23/2026 1078856030 CMS
Novocure Inc. $198.57 01/11/2024 Travel and Lodging Undisputed 01/23/2026 1119258002 CMS
Novocure Inc. $4,900.00 01/11/2024 Honoraria Undisputed 01/23/2026 1119258004 CMS
Orion Corporation $210.79 10/16/2024 Food and Beverage Undisputed 01/23/2026 1073840647 CMS
TAIHO ONCOLOGY, INC. $2,100.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1137944299 CMS
Takeda Pharmaceuticals U.S.A., Inc. $60.73 02/13/2024 Travel and Lodging Undisputed 01/23/2026 1144970841 CMS
Takeda Pharmaceuticals U.S.A., Inc. $8,371.51 02/14/2024 Travel and Lodging Undisputed 01/23/2026 1144970843 CMS
Takeda Pharmaceuticals U.S.A., Inc. $424.61 02/14/2024 Travel and Lodging Undisputed 01/23/2026 1144970845 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14,684.35 02/17/2024 Consulting Fee Undisputed 01/23/2026 1144970847 CMS
Takeda Pharmaceuticals U.S.A., Inc. $648.47 02/18/2024 Travel and Lodging Undisputed 01/23/2026 1144970849 CMS
Takeda Pharmaceuticals U.S.A., Inc. $90.10 02/18/2024 Food and Beverage Undisputed 01/23/2026 1144970851 CMS
Takeda Pharmaceuticals U.S.A., Inc. $69.91 02/19/2024 Travel and Lodging Undisputed 01/23/2026 1144970853 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.